Adverse events18

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 18 of 18

Type	Event	Organ system	Group	Affected	At risk
other	Irritation/soreness/swelling at injection sites	Skin and subcutaneous tissue disorders	Active Romosozumab 210mg Injection	8	20
other	Irritation/soreness/swelling at injection sites	Skin and subcutaneous tissue disorders	Placebo	1	10
other	COVID-19	Infections and infestations	Active Romosozumab 210mg Injection	1	20
other	COVID-19	Infections and infestations	Placebo	1	10
other	Nausea	Gastrointestinal disorders	Active Romosozumab 210mg Injection	1	20
other	Nausea	Gastrointestinal disorders	Placebo	0	10
other	Headache	General disorders	Active Romosozumab 210mg Injection	2	20
other	Headache	General disorders	Placebo	0	10
other	Vaginal Discharge	Reproductive system and breast disorders	Active Romosozumab 210mg Injection	1	20
other	Vaginal Discharge	Reproductive system and breast disorders	Placebo	0	10
other	Intermittent galactorrhea	Reproductive system and breast disorders	Active Romosozumab 210mg Injection	1	20
other	Intermittent galactorrhea	Reproductive system and breast disorders	Placebo	0	10
other	Bradycardia	Cardiac disorders	Active Romosozumab 210mg Injection	1	20
other	Bradycardia	Cardiac disorders	Placebo	0	10
other	Constipation	Gastrointestinal disorders	Active Romosozumab 210mg Injection	1	20
other	Constipation	Gastrointestinal disorders	Placebo	0	10
other	Musculoskeletal pain	Musculoskeletal and connective tissue disorders	Active Romosozumab 210mg Injection	1	20
other	Musculoskeletal pain	Musculoskeletal and connective tissue disorders	Placebo	0	10

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04779216/events